All articles by BV Swagath
BV Swagath
Everest Medicines launches IgA nephropathy drug Nefecon in China
Everest Medicines, a biopharmaceutical company listed in Hong Kong, has announced the launch of IgA nephropathy (IgAN) drug Nefecon in…
Bristol Myers Squibb to lay off 2,200 jobs under $1.5bn cost savings initiative
Bristol Myers Squibb has announced plans to lay off nearly 2,200 employees this year as part of an internal cost…
Zydus launches Mirabegron Extended-Release Tablets in the US
Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as “Zydus”) announces the launch of Mirabegron Extended-Release Tablets, 25 mg…
LENZ Therapeutics announces completion of merger with Graphite Bio
LENZ Therapeutics, Inc. (Nasdaq: LENZ) (LENZ or the Company), a late clinical-stage biopharmaceutical company focused on developing the first aceclidine-based…